Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | IGFBP2 |
| Upstream (Parents) |
|---|
| (<<) ADCY6 → IGFBP2 |
| (<<) ADCY7 → IGFBP2 |
| (<<) ADCY9 → IGFBP2 |
| (<<) BCL2A1 → IGFBP2 |
| (<<) CASP1 → IGFBP2 |
| (<<) CCND1 → IGFBP2 |
| (<<) CDH3 → IGFBP2 |
| (<<) CEBPB → IGFBP2 |
| (<<) CHI3L1 → IGFBP2 |
| (<<) COTL1 → IGFBP2 |
| (<<) CRYAB → IGFBP2 |
| (<<) CXCL1 → IGFBP2 |
| (<<) CYP1B1 → IGFBP2 |
| (<<) DDR1 → IGFBP2 |
| (<<) EGFR → IGFBP2 |
| (<<) ERBB3 → IGFBP2 |
| (<<) GLI3 → IGFBP2 |
| (<<) GSTM3 → IGFBP2 |
| (<<) HSD17B2 → IGFBP2 |
| (<<) IGFBP4 → IGFBP2 |
| (<<) IGFBP6 → IGFBP2 |
| (<<) KRT6B → IGFBP2 |
| (<<) LIPG → IGFBP2 |
| (<<) LPXN → IGFBP2 |
| (<<) MAFF → IGFBP2 |
| (<<) MAP3K5 → IGFBP2 |
| (<<) MLPH → IGFBP2 |
| (<<) MSN → IGFBP2 |
| (<<) PRNP → IGFBP2 |
| (<<) PTGER4 → IGFBP2 |
| (<<) RHOB → IGFBP2 |
| (<<) SGK1 → IGFBP2 |
| (<<) SLC29A1 → IGFBP2 |
| (<<) SLPI → IGFBP2 |
| (<<) SPDEF → IGFBP2 |
| (<<) TFF1 → IGFBP2 |
| Downstream (Children) |
|---|
| IGFBP2 → ATIC (>>) |
| IGFBP2 → ATP2C2 (>>) |
| IGFBP2 → CHODL (>>) |
| IGFBP2 → CKB (>>) |
| IGFBP2 → CXADR (>>) |
| IGFBP2 → ENO2 (>>) |
| IGFBP2 → FGFR2 (>>) |
| IGFBP2 → HDAC9 (>>) |
| IGFBP2 → HLA-DOA (>>) |
| IGFBP2 → HSPA2 (>>) |
| IGFBP2 → ITGB4 (>>) |
| IGFBP2 → KLF4 (>>) |
| IGFBP2 → NFATC4 (>>) |
| IGFBP2 → ORM1 (>>) |
| IGFBP2 → PI3 (>>) |
| IGFBP2 → PLCH2 (>>) |
| IGFBP2 → PRKCD (>>) |
| IGFBP2 → SLC20A1 (>>) |
| IGFBP2 → SMOX (>>) |
